The Complete Guide to SAFE Agreements for First-Time Founders
You've decided to raise. An angel sends a SAFE. You open the document and see "post-money," "valuation cap," "pro-rata," "MFN." You sign because everyone else seems to. Six months later you stack three more SAFEs and still haven't run the actual dilution math. This is how founders give away 35% when they thought they were giving away 15%. This guide fixes that.
What Is a SAFE Agreement?
A SAFE — Simple Agreement for Future Equity — is a contract that gives an investor the right to receive equity in your company at a future date, usually when you raise a priced round (like a Series A). It was created by Y Combinator in 2013 and has become the dominant instrument for US pre-seed and seed rounds.
It is not debt. There is no interest rate. There is no maturity date. The investor doesn't get their money back if the company fails — they get nothing, or whatever is left after liquidation preferences, depending on the terms.
What makes a SAFE useful:
- Speed: Two to three pages. A lawyer can review it in an hour. Closes in days, not weeks.
- Simplicity: No interest accrual, no maturity date negotiation, no debt on your balance sheet.
- Founder-aligned (when negotiated correctly): The investor doesn't get voting rights or board seats. They wait for the priced round.
- Standardised: The YC SAFE template means most experienced investors know what they're signing.
A SAFE has four key parameters that every founder must understand before signing:
- Valuation cap — the maximum price at which the SAFE converts
- Discount rate — a percentage discount from the Series A price, if any
- Pro-rata rights — the investor's right to participate in future rounds
- MFN clause — "most favoured nation" provision that can update terms automatically
Miss any of these and you'll understand the math too late.
Post-Money vs Pre-Money SAFEs: The Math That Actually Matters
This is the single most important distinction in SAFE fundraising. YC switched from pre-money to post-money SAFEs in 2018. Most founders still don't understand what changed — or why it matters enormously when you stack multiple SAFEs.
The Pre-Money SAFE (Legacy)
With a pre-money SAFE, the investor's ownership is calculated at conversion time, relative to the pre-money valuation at your priced round. If multiple SAFEs exist, all SAFE holders and new investors share dilution together.
The Post-Money SAFE (Current Standard)
With a post-money SAFE, the investor's ownership percentage is locked in at the time of signing — calculated against the post-money valuation cap. This means every subsequent SAFE or option pool expansion dilutes only the founders, not the existing SAFE investors.
Key insight: With post-money SAFEs, your dilution compounds with every new SAFE you issue. The first investor's percentage stays locked. The second investor's percentage stays locked. The founder's percentage absorbs every new note.
Worked Example: Two SAFEs, One Series A
Let's say you raise two SAFEs at a $10M post-money valuation cap:
- Angel A: $500K SAFE (post-money, $10M cap)
- Angel B: $500K SAFE (post-money, $10M cap, six months later)
Post-Money SAFE — Stacking Two Notes
| Investor | Investment | Cap | Locked Ownership % |
|---|---|---|---|
| Angel A | $500K | $10M post-money | 5.0% (locked at signing) |
| Angel B | $500K | $10M post-money | 5.0% (locked at signing) |
| Total SAFE dilution | $1M | — | 10.0% |
| Founder remaining | — | — | ~90% (before Series A) |
Now your Series A closes at a $40M pre-money valuation and investors take 20%. After SAFE conversion, the Series A dilution, and the option pool expansion (assume 10%), this is roughly where founders land:
Post-Series A Cap Table (Simplified)
| Stakeholder | Approximate Ownership |
|---|---|
| Founders | ~61% |
| Series A investors | ~20% |
| SAFE investors (A + B) | ~9% |
| Option pool | ~10% |
That's a reasonable outcome. But watch what happens if you issue a third SAFE at a higher cap, say $2M at a $20M post-money cap. Angel C gets 10% locked in. Now your two existing SAFE holders still have 5% each, Angel C has 10%, and the Series A takes 20%, plus the option pool. Founders can end up below 50% before they've taken a single institutional dollar.
Model your exact dilution before you sign
Stack up to 3 SAFEs, enter caps and amounts, get your post-conversion cap table in 30 seconds.
Valuation Caps and Discount Rates
The Valuation Cap
The cap is the single most negotiated SAFE term. It sets the maximum price at which the SAFE converts into equity at your priced round.
Example: Your SAFE has a $10M cap. Your Series A closes at a $40M pre-money valuation. The SAFE investor converts as if the round price were $10M — so they get four times as many shares per dollar as the Series A investors. This is the reward for investing early when risk was higher.
For founders, a lower cap means more dilution. A $5M cap is much more dilutive than a $15M cap for the same investment amount. Many first-time founders set the cap at "what feels right" without running the math against their Series A expectations. Don't do this.
The Discount Rate
A discount rate (typically 15–25%) gives the SAFE investor a discount off the Series A price, as an alternative to cap-based conversion. The investor gets whichever is better — the cap price or the discounted price.
Most sophisticated investors care primarily about the cap, not the discount. The discount matters most when the company raises a Series A at a valuation close to or below the SAFE cap. In practice, if your Series A is well above the cap, the discount is irrelevant.
Founder tip: A cap-only SAFE with no discount is simpler and cleaner. Many YC-style SAFEs use cap-only. If an angel insists on both, negotiate the discount down to 15% or remove it entirely in exchange for a lower cap.
5 Common SAFE Mistakes First-Time Founders Make
These mistakes don't blow up at signing. They surface at your Series A, in a data room, when you're trying to close a $10M round and an investor asks you to reconcile your cap table.
Not running dilution math before signing
Every SAFE has a price. That price is your ownership percentage. Founders who skip the model are essentially signing a blank check. Use a calculator before every note, not after the round closes.
Confusing "post-money" as the valuation
The "post-money valuation cap" in a post-money SAFE is not the valuation of your company. It's the cap used to calculate the investor's ownership. Many founders read a $10M post-money cap and think they've been valued at $10M. That's not what it means.
Stacking SAFEs at different caps without modeling the combined table
Three SAFEs at three different caps create three conversion tranches. Each one converts at a different share price. The combined dilution is almost always more than founders intuit. Stack them in a model before you issue the third one.
Ignoring MFN clauses
A "most favoured nation" clause means that if you issue a later SAFE on better terms, the MFN investor automatically receives those better terms. If you raise three rounds and each has lower caps, your first investors can claim the best terms. This gets messy fast at Series A due diligence.
Issuing SAFEs without considering the option pool impact
Option pools are usually created pre-Series A, which means they dilute founders — not SAFE investors. If you issue a 15% option pool after your SAFEs but before Series A closes, the SAFE investors maintain their locked percentages and founders absorb the full pool dilution.
Red Flags in SAFE Agreements
Most angels use YC's standard SAFE template. The moment someone proposes significant modifications, slow down. Here are the terms that warrant a lawyer's review before you sign anything:
Side letters with undisclosed provisions
Side letters that modify SAFE terms outside the main document are legal, but they create hidden complexity. At Series A, investors will request all side letters. Anything that wasn't disclosed early can kill or delay a deal.
Uncapped SAFEs
A SAFE with no valuation cap and only a discount is rare but dangerous. There's no ceiling on how much your early investor can capture if your Series A values the company very highly. Insist on a cap.
Broad "liquidity event" definitions
Some SAFEs define conversion triggers very broadly to include certain debt financings or secondary sales. If the SAFE converts in scenarios you didn't intend — like a bridge round — you could lose equity unexpectedly.
Pro-rata rights without a cap
Pro-rata rights are normal — they let investors maintain ownership through future rounds. But uncapped pro-rata rights on a small angel check can crowd out larger institutional investors at Series A. VCs sometimes pass on deals with too many small angels claiming pro-rata.
Conversion triggered by the SAFE investor's discretion
Standard SAFEs convert automatically on qualifying financing events. If an investor proposes language that lets them elect conversion timing, they gain leverage over your future fundraise. Reject this.
Negotiation Tips for First-Time Founders
You have more leverage than you think — especially on standard terms. Angels want to close quickly. Here's what to push on:
Anchor to your expected Series A valuation
The cap should reflect risk, not your current "self-assessed valuation." If you expect a $20M–$30M Series A in 18 months, a $10M cap is reasonable for an early check. Push back on caps below $8M unless the investor is writing a very meaningful check.
Remove MFN on all but the first note
MFN is most defensible for your first SAFE investor who took the earliest risk. By note three or four, MFN clauses create cascading complexity. Offer to remove MFN in exchange for no discount, or vice versa.
Limit pro-rata to a reasonable threshold
Standard pro-rata rights let investors maintain their percentage in future rounds. This is fair. But set a minimum check size threshold — for example, pro-rata rights only if the investor writes at least $250K. Small checks claiming pro-rata at Series A is a deal killer with institutional investors.
Insist on the YC standard template
Any deviation from the YC SAFE should be minimal and specific. "Our lawyers drafted a custom SAFE" is a red flag — not because it's necessarily bad, but because every modification costs your lawyer (and theirs) time, and creates ambiguity that surfaces at your next round.
Compare SAFE platforms before you choose one
SeedLegals vs Clerky vs Carta vs DIY — which is right for your stage and deal size?
SAFE vs Convertible Note: When to Use Which
The SAFE replaced the convertible note for most US seed rounds, but the note still has its place. Here's the straightforward breakdown:
SAFE vs Convertible Note — Key Differences
| SAFE | Convertible Note | |
|---|---|---|
| Interest | None | Accrues (typically 5–8%/year) |
| Maturity date | None | 12–24 months (repayment or conversion) |
| Debt on balance sheet | No | Yes |
| Document length | 2–3 pages | 8–15 pages |
| Investor familiarity (US) | Universal | Common, especially outside YC ecosystem |
| Jurisdictions | US-centric; SeedLegals SAFE for UK | Works across most jurisdictions |
| Repayment risk | None — investors lose if company fails | Technically repayable at maturity |
Use a SAFE when:
- Your investors are US-based and familiar with YC terms
- You need to close quickly and cheaply
- You don't want debt on your balance sheet
- You're raising pre-seed or seed from angels
Consider a convertible note when:
- Your investors are in markets where SAFEs have less legal precedent (UK, EU, Southeast Asia)
- Your investors specifically require a debt instrument
- A maturity date provides useful forcing-function alignment for both parties
For most US founders raising their first external capital, the SAFE wins on speed, cost, and simplicity. The convertible note is not "safer" — the word "safe" in SAFE refers to the agreement structure, not risk.
Related reading: For a full side-by-side breakdown — interest accrual, maturity risk, investor protections, geography, and exactly when to use each instrument — read Convertible Notes vs SAFEs: Which Is Right for Your Startup?
Preparing Your Cap Table for Series A
Series A due diligence will surface every SAFE, every side letter, every option grant, every cap table anomaly. Founders who prepare early close faster and negotiate from strength. Founders who discover problems during due diligence lose leverage at exactly the wrong moment.
Here's what investors audit:
- Fully diluted cap table with SAFEs modeled through conversion. Not a "current" cap table — a post-conversion cap table that reflects exactly how your existing SAFEs will convert at the assumed Series A price.
- All SAFE documents and any side letters. VCs will request these and compare them against your cap table. Discrepancies are red flags.
- MFN tracking. Which SAFEs have MFN clauses? Which notes were issued at the lowest cap — those are the terms an MFN holder can claim.
- Option pool status. How many options have been granted versus authorised? Any unexercised options from departed employees? These need to be cleaned up before diligence.
- 409A valuation. Your current 409A should be no more than 12 months old at the time of the Series A.
Start this 6 months early. The founders who close cleanest aren't the ones who scramble during due diligence — they're the ones who kept their cap table current, documented every SAFE at issuance, and ran the conversion model before they needed it.
Is your cap table Series A ready?
Run through the 40-point Series A readiness checklist — the same audit institutional investors run at due diligence.
Before You Sign: A SAFE Founder Checklist
Every time you're handed a SAFE to sign, work through this list before you counter or execute:
- ✅ Is this post-money or pre-money? Know which type you're signing. If it's post-money (standard post-2018 YC), the investor's ownership is locked at signing.
- ✅ Have you run the dilution model? Enter the cap, investment amount, and expected Series A valuation into a calculator. Know your post-conversion ownership before you sign.
- ✅ What does your combined cap table look like with this note added? Don't assess each SAFE in isolation — look at all outstanding notes together.
- ✅ Are there MFN clauses in any existing SAFEs? If yes, is this new SAFE on better terms? If so, existing MFN holders may be entitled to upgrade.
- ✅ What are the pro-rata rights? Is there a minimum check threshold? What happens if this investor wants to exercise pro-rata at Series A?
- ✅ Is this the YC standard template? Any material deviation should be reviewed by your attorney before signing.
- ✅ Are there side letters? If yes, what do they say, and are they disclosed to all other investors?
SAFEs are fast, but fast doesn't mean careless. A 20-minute model review before signing saves 20 hours of cap table cleanup at Series A.
Get the SAFE Calculator & Comparison Guide
We'll send you a link to model your exact dilution and compare SAFE platforms. No fluff.
No spam. Unsubscribe anytime.